Quanterix and Akoya Biosciences Announce Amended Merger Agreement

About this update from Quanterix Corporation

[{"type":"text","content":"Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination","length":93,"tagName":"p","attribs":{}},{"type":"text","content":"BILLERICA, Mass. & MARLBOROUGH, Mass., April 29, 2025--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement.","length":351,"tagName":"p"},{"type":"text","content":"Under the amended terms, Quanterix will issue approximately 7.76 million shares of its common stock and pay $20 million in cash to Akoya shareholders. Each Akoya share will receive $0.38 per share in cash and 0.1461 shares of Quanterix common stock.","length":249,"tagName":"p"},{"type":"text","content":"With the amended exchange ratio, Quanterix will issue over 9 million fewer shares than under the original deal terms. Quanterix shareholders will own approximately 84% of the combined company and Akoya shareholders will own approximately 16%.","length":242,"tagName":"p"},{"type":"text","content":"Masoud Toloue, PhD, Chief Executive Officer of Quanterix, said, "The strategic merits of the transaction remain strong even as the market has been focused on academic funding and tariff concerns. In light of recent volatility, we re-engaged with Akoya to revise the terms of the agreement. The combined company will provide a significant value creation opportunity for shareholders."","length":393,"tagName":"p"},{"type":"text","content":"Brian McKelligon, Chief Executive Officer of Akoya, said, "We remain excited to combine with Quanterix and believe this partnership offers compelling value for Akoya shareholders. We look forward to closing the transaction and leveraging our collective scale to drive synergies across our organizations and customers, expediting our path to profitability."","length":366,"tagName":"p"},{"type":"text","content":"Additional Details about the Transaction","length":40,"tagName":"p"},{"type":"text","content":"The revised transaction terms and amended merger agreement have been approved by the Quanterix Board and the Akoya Board, respectively.","length":135,"tagName":"p"},{"type":"text","content":"Shareholders of Akoya who hold more than 5...

More updates from Quanterix Corporation